Contents
15 Member States have so far received a total of €53.5 billion under the SURE instrument. The Commission disbursed €13 billion to six EU countries in the sixth instalment of financial support under the SURE instrument. Czechia received trading solutions provider €1 billion, Belgium €2.2 billion, Spain €4.06 billion, Ireland €2.47 billion, Italy €1.87 billion and Poland €1.4 billion. The European Commission reached an agreement with BioNTech-Pfizer to speed up the delivery of vaccines.
The protection of employment was crucial to facilitate the rapid economic rebound in 2021, which was faster than in previous crises. SURE helped to enable this by financing schemes to allow firms to retain employees and skills, and to help the self-employed to be ready to resume their activities immediately, as well as by boosting confidence across the EU. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Thursday Predictions: 3 Hot Stocks for Tomorrow
More than 50% of the long-term EU budget and Next Generation EU – a total of some €1,8 trillion – will support modern policies and set Europe on path to a sustainable and resilient recovery. The Commission proposed the extension of the 2020 European Capitals of Culture year until 30 April 2021 for Rijeka and Galway . The Commission also proposed to postpone the year in which Novi Sad is due to host a European Capital of Culture, from 2021 to 2022, and the year in which Timisoara and Elefsina will hold the title, from 2021 to 2023. The Commission confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere, for everyone who needs them.
- But the foundation hasn’t just handed money over to drugmakers; it’s also invested in a few of them.
- The Pfizer-BioNTech lower dose COVID-19 vaccine is currently the only one available for children between the ages of 5–11.
- The Commission has adopted a third amendment to extend the scope of the State aid Temporary Framework adopted on 19 March 2020 that wouldenable Member States to further support micro, small and start-up companies.
- Pfizer is navigating the switch from government purchasing for its existing Covid products to the commercial market.
- To prepare for the future, the Commission also announced it was entering into a negotiation with BioNTech-Pfizer for a third contract that would foresee the delivery of 1.8 billion doses of vaccine over the period of 2021 to 2023.
- The Commission disbursed €289 million to Lithuania in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility.
The EU and AstraZeneca have reached an agreement which will secure the delivery of the remaining COVID-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca. The European Commission issued the first NextGenerationEU green bond, thus raising €12 billion to be used exclusively for green and sustainable investments across the EU. Based on the recommendation of the European Medicines Agency, the Commission authorised the first two COVID-19 booster vaccines adapted to variants, from BioNTech Pfizer and Moderna. Our mission is to end childhood health epidemics by working aggressively to eliminate harmful exposures, hold those responsible accountable, and to establish safeguards to prevent future harm. Though a COVID-19 vaccine could certainly boost Pfizer’s fortunes, the big drugmaker’s future success doesn’t depend on it. It had already made significant progress with this program when it announced a partnership with Pfizer in March.
JPMorgan downgrades EVgo shares to overweight
This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency and is endorsed by the EU countries. The Commission proposed immediate action to prepare Europe for the increased threat of coronavirus variants, including through the new European bio-defence preparedness plan called“HERA Incubator” . €9 billion were disbursed to seven EU countries in the fifth instalment of financial support under the SURE instrument. Czechia received €1 billion, Spain €2.87 billion, Croatia €510 million, Italy €3.87 billion, Lithuania €302 million, Malta €123 million and Slovakia €330 million. These loans will assist EU countries in addressing sudden increases in public expenditure to preserve employment. To date, 16 EU countries have received a total of €62.5 billion under the SURE instrument in back-to-back loans.
Once the Council approves these proposals, the financial support will be provided in the form of loans granted on favourable terms from the EU to Member States. The first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force. The contract will allow the purchase of a vaccine against COVID-19 for all the EU Member States, as well as the donation to lower and middle income countries or the re-direction to other European countries. Through the contract, all Member States will be able to purchase 300 million doses of the AstraZeneca vaccine, with an option for further 100 million doses, to be distributed on a population-based pro-rata basis.
The Commission has proposed to update the rules on coordination of safe and free movement in the EU, which were put in place in response to the COVID-19 pandemic. The Commission also proposed to update the Council recommendation on non-essential travel from outside top 5 most accurate intraday trading indicators the EU to simplify the framework and reflect recent developments, prioritising vaccinated travellers, with strong safeguards. The EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021.
The Commission proposed a macro-financial assistance package worth €3 billion for ten enlargement and neighbourhood partners to help them limit the economic fallout of the coronavirus pandemic. The proposal comes on top of the ‘Team Europe’ strategy, the EU’s robust and targeted response to support partner countries’ efforts in tackling the coronavirus pandemic. The Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. The Council adopted a regulation establishing the Recovery and Resilience Facility, which lies at the heart of the EU’s recovery plan. EU countries will receive support from the facility on the basis of their national recovery and resilience plans, which are currently under preparation.
Other PFE Stock News
VIR-7832 could potentially be used to treat COVID-19 and as a vaccine to prevent infection. In addition, the biotech is conducting preclinical studies of an inhaled therapy targeting COVID-19. It’s not surprising that the Bill & Melinda Gates Foundation also owns shares of BioNTech. Again, though, the nonprofit foundation didn’t invest in the German biotech stock because of its coronavirus program.
The pre-financing payment will help to kick-start the implementation of the crucial investment and reform measures outlined in Malta’s recovery and resilience plan. The Commission disbursed €271 million to Finland in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help kick-start the implementation of the crucial investment and reform measures outlined in Finland’s recovery and resilience plan. It will provide critical and targeted support in key areas such as health, water, sanitation and hygiene. The newly adopted package brings the total assistance mobilised through the EU Trust Fund to over €2.2 billion since 2015, doubling the target originally set.
How much is Pfizer worth?
The EIB financing is backed by both Horizon2020 InnovFin and the European Fund for Strategic Investments. On 24 June 2020, the second of two EU Humanitarian Air Bridge flights arrived in Sudan, helping humanitarian workers and essential supplies reach people in need and supporting the coronavirus response in the country. This fully EU-funded Humanitarian Air Bridge flight to Sudan was made possible through a coordinated Team Europe approach, bringing together the European Union, Sweden, France and the Humanitarian Logistics Network. Countries supported include Afghanistan, Burkina Faso, the Central African Republic, the Democratic Republic of Congo, Iran, Sudan, South Sudan, Haiti, Somalia, Guinea Bissau, Iraq and Yemen.
What should I know before trading Pfizer stock?
Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services.
Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
This is an important step towards the EU disbursing €3.5 billion in grants under the Recovery and Resilience Facility and will help Austria emerge stronger from the COVID-19 pandemic. The Commission disbursed €800 million in payments under NextGenerationEU, the temporary instrument to finance Europe’s recovery and foster a greener, more digital and resilient economy after the pandemic. The payments went to 41 national and regional programmes in 16 Member States from theRecovery Assistance for Cohesion and the Territories of Europe initiative (REACT-EU).
The European Commission has complemented the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Following new offers of assistance from EU Member States to countries in need, the Commission has so far supported the sharing of over 3 million COVID-19 vaccines with countries outside of the EU through the European Civil Protection Mechanism. The Commission decided to prolong until 30 June 2022 the State aid Temporary Framework https://forexdelta.net/ . In order to further accelerate the recovery, the Commission has also decided to introduce two new measures to create direct incentives for forward-looking private investment and solvency support measures, for an additional limited period. In its first bond syndication of 2022, the Commission raised a further €5 billion in NextGenerationEU funds on behalf of the EU in yet another successful deal. Due on 6 July 2051, the 30-year bond – executed as an increase to an existing EU-Bond – brings the total financing raised under the programme to €78.5 billion.
The Commission disbursed €2.25 billion to Germany in pre-financing, equivalent to 9% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help kick-start the implementation of the crucial investment and reform measures outlined in Germany’s recovery and resilience plan. The Commission disbursed €201 million to Denmark in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility.
Additional exceptional measures were proposed to further support agricultural and food markets most affected. The European Commission has set up an EU Humanitarian Air Bridge to transport humanitarian workers and emergency supplies for the coronavirus response to some of most critical areas around the world. The Council adopted the Commission’s proposal for a temporary derogation from the rules governing “European Companies ” and the European Cooperative Society , only four weeks after the Commission had proposed it. The measures will allow European Companies and the European Cooperative Societies to exceptionally hold their general meetings within twelve months of the end of the financial year, instead of within six months as provided for in the legislation. To ensure the recovery is sustainable, even, inclusive and fair for all Member States, the European Commission has proposed to create a new recovery instrument, Next Generation EU, embedded within a powerful, modern and revamped long-term EU budget.
They will also have the possibility to purchase vaccines for an additional 200 million people. The Commission has already signed a contract with AstraZeneca and with Sanofi-GSK and concluded successful exploratory talks with CureVac, BioNTech-Pfizer and Moderna. The Commission disbursed €915 million to Czechia in a pre-financing payment under the Recovery and Resilience Facility.
That’s above the 2.8% Dow Jones estimate, but represents a slight cooldown from the third-quarter reading. As an immediate first response, EU Member States mobilised and delivered a total of 12 tons of protective equipment to China. The first out of four joint procurements of personal protective equipment was launched together with Member States. This turns the EU into one big buyer, encouraging suppliers to move quickly at scale and provide the maximum equipment possible at the best price. As of 24 March, producers have made offers covering, and in some cases even exceeding, the quantities requested.
Four of these therapeutics are monoclonal antibodies under rolling review by the European Medicines Agency. Another one is an immunosuppressant, which has a marketing authorisation that could be extended to include the treatment of COVID-19 patients. In its second NextGenerationEU transaction, the Commission raised €15 billion to finance Europe’s recovery from the coronavirus crisis and its consequences.
The European Commission has granted a conditional marketing authorisation for the COVID‑19 vaccine developed by Novavax. The European Commission has today issued €8 billion in a dual tranche transaction under the NextGenerationEU recovery instrument. The deal was the 11th syndicated transaction under NextGenerationEU and the 6th in 2022.
The Commission presented a Communication on the early lessons learnt from the COVID-19 pandemic over the past 18 months and building on them to improve action at EU and national level. This will help to better anticipate public health risks and enhance contingency planning leading to swifter and more effective joint responses at all levels. These therapeutics will bring treatment to patients across the EU as fast as possible provided that their safety and effectiveness has been confirmed by the European Medicines Agency. The Commission proposed to extend the EU Digital COVID Certificate by a year, until 30 June 2023. Extending the Regulation will ensure that travellers can continue using their EU Digital COVID Certificate when travelling in the EU where Member States maintain certain public health measures. The Commission proposed a set of actions to manage the current phase of the COVID-19 pandemic and prepare for the next one.